User profiles for Pedro Chaná-Cuevas
Pedro Chaná-CuevasProfessor of Neurology, CETRAM, Universidad de Santiago Verified email at cetram.org Cited by 873 |
[HTML][HTML] Evaluación de la sobrecarga en los cuidadores de los pacientes con enfermedad de Parkinson ambulatorios y sus factores de riesgo
…, D Alburquerque, P Chaná-Cuevas - Revista médica de …, 2013 - SciELO Chile
BENAVIDES, Olga; ALBURQUERQUE, Daniela y CHANA-CUEVAS, Pedro. Evaluación de
la sobrecarga en los cuidadores de los pacientes con enfermedad de Parkinson …
la sobrecarga en los cuidadores de los pacientes con enfermedad de Parkinson …
[HTML][HTML] Evaluación de síntomas no motores y descontrol de impulsos en usuarios con enfermedad de Parkinson por el médico en atención primaria
P Salles Gándara, P Chaná-Cuevas - Revista médica de Chile, 2020 - SciELO Chile
La Enfermedad de Parkinson (EP) es la segunda patología neurodegenerativa más frecuente
después de la enfermedad de Alzheimer. Su prevalencia se estima en 1 a 2 por 1.000 …
después de la enfermedad de Alzheimer. Su prevalencia se estima en 1 a 2 por 1.000 …
Evaluación del deterioro cognitivo en una población de pacientes con enfermedad de Parkinson mediante el test minimental Parkinson
TP Díaz, C Juri-Claverías, PC Cuevas… - Revista de …, 2005 - dialnet.unirioja.es
Introducción. La enfermedad de Parkinson (EP) es un cuadro neurodegenerativo en el que
inicialmente predominan los síntomas motores; sin embargo, con la progresión de la …
inicialmente predominan los síntomas motores; sin embargo, con la progresión de la …
[PDF][PDF] Distonía del guitarrista: tratamiento con reeducación sensorial
P Chaná-Cuevas, C Kunstmann-Rioseco… - Rev …, 2003 - researchgate.net
GUITARIST’S CRAMP: TREATMENT WITH SENSORY RE-EDUCATION Resumen. Introduction.
Dystonia is defined as a sustained co-contraction of agonistic and antagonistic muscles …
Dystonia is defined as a sustained co-contraction of agonistic and antagonistic muscles …
[HTML][HTML] The potential role of SARS-COV-2 in the pathogenesis of Parkinson's disease
P Chana-Cuevas, P Salles-Gandara… - Frontiers in …, 2020 - frontiersin.org
Considering their current burden and epidemiological projections, nowadays Parkinson's
disease and the COVID-19 pandemic are two key health problems. There is evidence of the …
disease and the COVID-19 pandemic are two key health problems. There is evidence of the …
[HTML][HTML] New perspectives in iron chelation therapy for the treatment of neurodegenerative diseases
MT Nuñez, P Chana-Cuevas - Pharmaceuticals, 2018 - mdpi.com
Iron chelation has been introduced as a new therapeutic concept for the treatment of
neurodegenerative diseases with features of iron overload. At difference with iron chelators used in …
neurodegenerative diseases with features of iron overload. At difference with iron chelators used in …
Characterizing the genetic architecture of Parkinson's disease in Latinos
…, F Lopera, S Moreno, P Chana‐Cuevas… - Annals of …, 2021 - Wiley Online Library
Objective This work was undertaken in order to identify Parkinson's disease (PD) risk
variants in a Latino cohort, to describe the overlap in the genetic architecture of PD in Latinos …
variants in a Latino cohort, to describe the overlap in the genetic architecture of PD in Latinos …
Insulin-like growth factor 2 (IGF2) protects against Huntington's disease through the extracellular disposal of protein aggregates
…, DR Henríquez, L Plate, P Chana-Cuevas… - Acta …, 2020 - Springer
Impaired neuronal proteostasis is a salient feature of many neurodegenerative diseases,
highlighting alterations in the function of the endoplasmic reticulum (ER). We previously …
highlighting alterations in the function of the endoplasmic reticulum (ER). We previously …
[HTML][HTML] Analysis of four scales for global severity evaluation in Parkinson's disease
…, VC Arillo, W Fernández, P Chaná-Cuevas… - npj Parkinson's …, 2016 - nature.com
Global evaluations of Parkinson’s disease (PD) severity are available, but their
concordance and accuracy have not been previously tested. The present international, cross-sectional …
concordance and accuracy have not been previously tested. The present international, cross-sectional …
[HTML][HTML] Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody
Despite unprecedented global efforts to rapidly develop SARS-CoV-2 treatments, in order to
reduce the burden placed on health systems, the situation remains critical. Effective …
reduce the burden placed on health systems, the situation remains critical. Effective …